Percutaneous pulmonary valve implantation for right ventricular outflow tract defects
HAYES, Inc.
Record ID 32016000780
English
Authors' recommendations:
Purpose of Technology: Percutaneous pulmonary valve implantation (PPVI), also referred to as transcatheter or catheter-based pulmonary valve implantation or replacement, is a minimally invasive heart surgery in patients with right ventricular outflow tract (RVOT) defects. The procedure involves the percutaneous, catheter-based deployment and placement of a pulmonary valve prosthesis. The purpose of PPVI is to improve hemodynamics, cardiopulmonary function, and survival while delaying the need for surgical repair of a dysfunctional RVOT.
Relevant Questions: Is PPVI for RVOT effective, i.e., does it improve hemodynamic measures, cardiopulmonary function, and survival, and reduce pulmonary artery regurgitation and disease-related mortality without leading to a high number of failures or reinterventions? Is PPVI safe? Have definitive patient selection criteria been established for PPVI for RVOT?
Details
Project Status:
Completed
Year Published:
2016
URL for published report:
The report may be purchased from:
http://www.hayesinc.com/hayes/crd/?crd=16094
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Humans
- Heart Valve Prosthesis Implantation
- Heart Ventricles
- Pulmonary Valve
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
2014 Winifred S. Hayes, Inc
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.